X hits on this document

115 views

0 shares

0 downloads

0 comments

25 / 30

April 2006

A Phase III Randomized, Open-Label, International Study Comparing Lapatinib and Capecitabine vs. Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer (EGF100151)

Study Enrollment Terminated due to Positive Interim Analysis

Document info
Document views115
Page views115
Page last viewedTue Jan 17 23:26:51 UTC 2017
Pages30
Paragraphs319
Words1235

Comments